Eric C Holland Selected Research

Eric C Holland Research Topics

Disease

113	Neoplasms (Cancer) 04/2024 - 01/2002
67	Glioma (Gliomas) 04/2024 - 01/2002
46	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 08/2002
25	Brain Neoplasms (Brain Tumor) 01/2023 - 03/2004
7	Carcinogenesis 10/2022 - 07/2004
6	Astrocytoma (Pilocytic Astrocytoma) 11/2019 - 02/2005
5	Oligodendroglioma 10/2011 - 11/2004
5	Medulloblastoma 09/2009 - 05/2003
4	Ependymoma 01/2023 - 01/2017
3	Meningioma (Meningiomas) 01/2024 - 10/2012
3	Brain Injuries (Brain Injury) 08/2011 - 01/2007
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2017
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 10/2020 - 01/2020
2	Primitive Neuroectodermal Tumors (PNET) 01/2009 - 01/2002
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Rhabdoid Tumor (Rhabdoid Tumors) 11/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Hemangiosarcoma (Angiosarcoma) 01/2021
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2002
16	RNA (Ribonucleic Acid)IBA 04/2024 - 08/2002
14	Platelet-Derived Growth FactorIBA 01/2021 - 07/2004
11	Phosphotransferases (Kinase)IBA 03/2024 - 04/2005
11	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2018 - 07/2004
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2002
10	NestinIBA 01/2017 - 01/2002
9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024 - 12/2016
9	Temozolomide (Temodar)FDA LinkGeneric 04/2024 - 08/2005
7	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2022 - 07/2004
7	LigandsIBA 12/2020 - 12/2006
7	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2005
6	MicroRNAs (MicroRNA)IBA 01/2023 - 06/2009
6	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 12/2007
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2005
5	perifosineIBA 01/2020 - 08/2005
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012 - 01/2007
4	EnzymesIBA 01/2020 - 08/2004
4	LuciferasesIBA 01/2020 - 12/2005
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2024 - 09/2007
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2016
3	tyrosine receptor (receptor, tyrosine)IBA 12/2020 - 04/2005
3	Peptides (Polypeptides)IBA 01/2018 - 03/2004
3	Messenger RNA (mRNA)IBA 01/2012 - 07/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2024 - 10/2010
2	ElementsIBA 01/2023 - 10/2012
2	Protein Isoforms (Isoforms)IBA 10/2022 - 09/2011
2	Histones (Histone)IBA 11/2021 - 12/2015
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2006
2	Virus ReceptorsIBA 01/2021 - 01/2017
2	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2021 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2007
2	VaccinesIBA 01/2021 - 01/2018
2	CytokinesIBA 01/2021 - 10/2020
2	Chimeric Antigen ReceptorsIBA 10/2020 - 01/2018
2	AntibodiesIBA 10/2020 - 04/2007
2	epidermal growth factor receptor VIIIIBA 01/2020 - 12/2007
2	temsirolimus FDA Link 01/2020 - 01/2011
2	TensinsIBA 01/2020 - 12/2007
2	InterferonsIBA 01/2020 - 10/2013
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2018 - 04/2007
2	OsteopontinIBA 01/2018 - 03/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 01/2016
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2016 - 01/2007
2	GoldIBA 01/2015 - 10/2014
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2015 - 10/2014
2	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2014 - 06/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2013 - 01/2010
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2011 - 10/2006
2	Alkylating AgentsIBA 09/2011 - 08/2005
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2011 - 10/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2010 - 09/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2010 - 11/2005
2	Insulin-Like PeptidesIBA 09/2009 - 08/2004
1	Cellular Retinol-Binding ProteinsIBA 04/2024
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2024
1	AcidsIBA 04/2024
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2024
1	Mitochondrial DNA (mtDNA)IBA 03/2024
1	RNA Polymerase II (RNA Polymerase B)IBA 03/2024
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 10/2022
1	TropomyosinIBA 10/2022
1	Ribonucleases (Ribonuclease)IBA 01/2022
1	angiogeninIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	LipopolysaccharidesIBA 01/2021
1	Interferon Type IIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	trametinibIBA 01/2021
1	AntigensIBA 01/2021
1	ponatinibIBA 01/2021
1	cediranib (AZD2171)IBA 01/2021

Therapy/Procedure

35	Therapeutics 04/2024 - 01/2002
11	Radiotherapy 04/2024 - 01/2012
6	Immunotherapy 04/2024 - 01/2018
5	Transplantation 05/2016 - 01/2004
5	Drug Therapy (Chemotherapy) 05/2015 - 12/2007